Literature DB >> 1206479

Importance of assay specificity for plasma protein binding determinations.

A Yacobi, G Levy.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1206479     DOI: 10.1007/bf01059475

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  4 in total

1.  Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

2.  Letter: Effect of plasma protein binding on elimination of warfarin.

Authors:  G Levy; A Yacobi
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

3.  Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors:  A Yacobi; L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1974-06       Impact factor: 3.534

4.  The assay of warfarin in plasma or stool.

Authors:  R J Lewis; L P Ilnicki; M Carlstrom
Journal:  Biochem Med       Date:  1970-12
  4 in total
  6 in total

1.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Protein binding of warfarin.

Authors:  G Levy
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

3.  Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

4.  Calculation of drug concentration in plasma after equilibrium dialysis.

Authors:  K M Giacomini; A Abang; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

6.  In vivo interaction of the enantiomers of disopyramide in human subjects.

Authors:  K M Giacomini; W L Nelson; R A Pershe; L Valdivieso; K Turner-Tamiyasu; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1986-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.